(BBH) Holdings - VanEck Biotech
Potfolio Holdings BBH, Valuations and Growth Rates, Asset Allocations, Country and Market Cap Distributions.
BBH Top Holdings (24)
| Symbol | Name | Sector | Industry | Country | Assets % |
|---|---|---|---|---|---|
|
AMGN NASDAQ Amgen |
Amgen Inc | Healthcare | Drug Manufacturers - General |
United States US North America |
17.41% |
|
GILD NASDAQ Gilead Sciences |
Gilead Sciences Inc | Healthcare | Drug Manufacturers - General |
United States US North America |
13.4% |
|
VRTX NASDAQ Vertex Pharmaceuticals |
Vertex Pharmaceuticals Inc | Healthcare | Biotechnology |
United States US North America |
11.84% |
|
REGN NASDAQ Regeneron Pharmaceuticals |
Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology |
United States US North America |
6.27% |
|
ARGX NASDAQ argenx |
argenx NV ADR | Healthcare | Biotechnology |
United States US North America |
5.16% |
|
NTRA NASDAQ Natera |
Natera Inc | Healthcare | Diagnostics & Research |
United States US North America |
4.32% |
|
IQV NYSE IQVIA Holdings |
IQVIA Holdings Inc | Healthcare | Diagnostics & Research |
United States US North America |
4.29% |
|
ALNY NASDAQ Alnylam Pharmaceuticals |
Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology |
United States US North America |
3.73% |
|
ICLR NASDAQ ICON |
ICON PLC | Healthcare | Diagnostics & Research |
United States US North America |
3.26% |
|
BIIB NASDAQ Biogen |
Biogen Inc | Healthcare | Drug Manufacturers - General |
United States US North America |
3.01% |
|
ILMN NASDAQ Illumina |
Illumina Inc | Healthcare | Diagnostics & Research |
United States US North America |
2.79% |
|
BNTX NASDAQ BioNTech SE |
BioNTech SE | Healthcare | Biotechnology |
United States US North America |
2.5% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology |
United States US North America |
2.39% |
|
INSM NASDAQ Insmed |
Insmed Inc | Healthcare | Biotechnology |
United States US North America |
2.25% |
|
NBIX NASDAQ Neurocrine Biosciences |
Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty... |
United States US North America |
2.17% |
|
MRNA NASDAQ Moderna |
Moderna Inc | Healthcare | Biotechnology |
United States US North America |
2.02% |
|
SRPT NASDAQ Sarepta Therapeutics |
Sarepta Therapeutics Inc | Healthcare | Biotechnology |
United States US North America |
1.93% |
|
TECH NASDAQ Bio-Techne |
Bio-Techne Corp | Healthcare | Biotechnology |
United States US North America |
1.79% |
|
INCY NASDAQ Incyte |
Incyte Corporation | Healthcare | Biotechnology |
United States US North America |
1.66% |
|
CRL NYSE Charles River Laboratories |
Charles River Laboratories | Healthcare | Diagnostics & Research |
United States US North America |
1.59% |
|
RGEN NASDAQ Repligen |
Repligen Corporation | Healthcare | Medical Instruments & Supplies |
United States US North America |
1.4% |
|
BMRN NASDAQ Biomarin Pharmaceutical |
Biomarin Pharmaceutical Inc | Healthcare | Biotechnology |
United States US North America |
1.4% |
|
EXAS NASDAQ EXACT Sciences |
EXACT Sciences Corporation | Healthcare | Diagnostics & Research |
United States US North America |
1.17% |
|
CYTK NASDAQ Cytokinetics |
Cytokinetics Inc | Healthcare | Biotechnology |
United States US North America |
0.62% |
BBH Sectors
| Equity % | Relative to Category | |
|---|---|---|
| Basic Materials | 0% | 0% |
| Consumer Cyclicals | 0% | 0% |
| Financial Services | 0% | 0.05% |
| Real Estate | 0% | 0.11% |
| Communication Services | 0% | 0% |
| Energy | 0% | 0.02% |
| Industrials | 0% | 0.04% |
| Technology | 0% | 0% |
| Consumer Defensive | 0% | 0.06% |
| Healthcare | 100% | 99.72% |
| Utilities | 0% | 0% |
BBH Valuations and Growth Rates
| Valuations Rates Portfolio | Valuations Rates To Category | Growth Rates Portfolio | Growth Rates To Category | |
|---|---|---|---|---|
| Price/Prospective Earnings | 16.33 | 21.05 | ||
| Price/Book | 4.58 | 5.06 | ||
| Price/Sales | 4.59 | 2.96 | ||
| Price/Cash Flow | 13.85 | 19.71 | ||
| Dividend-Yield Factor | 1.06 | 0.97 | ||
| Long-Term Projected Earnings Growth | 5.51 | 11.4 | ||
| Historical Earnings Growth | -14.07 | -1.12 | ||
| Sales Growth | 3.32 | 9.74 | ||
| Cash-Flow Growth | -9.04 | -6.38 | ||
| Book-Value Growth | 5.16 | 7.58 |
BBH Country Distribution
| Equity % | Relative to Category | |
|---|---|---|
| North America | 95.1% | 90.83% |
| United Kingdom | 0% | 1.91% |
| Europe Developed | 2.51% | 6.14% |
| Europe Emerging | 0% | 0% |
| Africa/Middle East | 0% | 0.2% |
| Japan | 0% | 0.46% |
| Australasia | 0% | 0.09% |
| Asia Developed | 0% | 0.03% |
| Asia Emerging | 2.4% | 0.35% |
| Latin America | 0% | 0% |
BBH Asset Allocations
| Long % | Short % | Net Assets % | |
|---|---|---|---|
| Cash | 0.09% | 0% | 0.09% |
| NotClassified | 0% | 0% | 0% |
| Stock non-US | 4.9% | 0% | 4.9% |
| Other | 0% | 0% | 0% |
| Stock US | 95.02% | 0% | 95.02% |
| Bond | 0% | 0% | 0% |
BBH Market Cap Distribution of Holdings
| Mega | Big | Medium | Small | Micro |
|---|---|---|---|---|
| 2.39% | 48.92% | 37.85% | 8.25% | 0% |